From February 18, 2022 to March 31, 2022, the company has repurchased 43,821 shares, representing 0.72% for KRW 5,450.18 million. With this, the company has completed the repurchase of 43,821 shares, representing 0.72% for KRW 5,450.18 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
131,500 KRW | -1.05% |
|
-5.33% | -45.44% |
May. 16 | Medy-Tox Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.44% | 640M | |
+0.75% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+73.89% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- A086900 Stock
- News Medy-Tox Inc.
- Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on February 18, 2022.